LiviWell Secures FDA Clearance for a New Class of Post-Sex Vaginal Care

MOUNTAIN LAKES, NJ – March 24, 2026 – In a move that signals a new frontier in women's intimate health, LiviWell today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for Livi, a first-of-its-kind device designed to manage post-intercourse fluids. The clearance introduces a novel product category aimed at addressing common, yet often unspoken, concerns about comfort and vaginal health after sex.

Livi is a single-use, tampon-like device intended for temporary vaginal insertion after intercourse to absorb semen and other fluids. For many women, the post-sex experience can involve discomfort, leakage, and concerns about odor, issues that have historically been managed with makeshift solutions or simply endured. LiviWell aims to change that by providing a medically recognized and purpose-built tool.

"Receiving FDA clearance for Livi marks a defining milestone for LiviWell and signals the introduction of a new category in women's intimate health," said Dawn Halkuff, Chief Executive Officer of LiviWell. "For too long, the realities women experience after sex have gone largely unaddressed by innovation. This clearance allows us to bring a simple, easy-to-use solution to market - one that fits seamlessly into a woman's routine and helps her feel more comfortable and confident."

A New Standard for Post-Intercourse Comfort

The Livi device is engineered for simplicity and discretion. Made from soft, medical-grade polyurethane foam, it is inserted with a biodegradable applicator similar to a tampon. According to the company, the device can absorb fluids in approximately 60 seconds and is designed to be left in place for up to 15 minutes before easy removal and disposal. Its function is purely absorptive, providing a targeted solution without introducing chemicals or fragrances into the vaginal environment.

This innovation steps into a void in the feminine hygiene market. While shelves are stocked with products for menstruation and daily cleansing, a dedicated, FDA-cleared device for post-intercourse fluid management has been absent. Women have traditionally resorted to using panty liners, immediately showering, or simply waiting out the discomfort of leakage—practices that do not address the underlying biological changes occurring within the vagina.

The Science of Vaginal pH

LiviWell's innovation is grounded in established medical science concerning the vaginal microbiome. A healthy vaginal environment is naturally acidic, with a pH typically ranging from 3.8 to 4.5. This acidity is maintained by beneficial bacteria, primarily Lactobacillus species, and serves as a crucial defense mechanism against the overgrowth of harmful pathogens.

Semen, however, is alkaline, with a much higher pH. When introduced into the vagina, it can temporarily disrupt this delicate acidic balance. This shift in pH can create a more favorable environment for odor-causing bacteria and may increase the risk of common infections like bacterial vaginosis (BV).

"From a clinical perspective, many patients have questions about post-sex complaints such as discharge and odor," explained Dr. Michael Ingber, a board-certified urogynecologist and LiviWell's Co-Founder and Chief Medical Officer. "Our research has shown that semen disrupts vaginal pH and can contribute to those common post-intercourse complaints. Conversations around post-sex vaginal health have historically been limited. Achieving FDA clearance for Livi represents an important step toward bringing greater medical recognition and innovative solutions to women experiencing these everyday concerns."

By quickly absorbing semen, Livi is designed to help the vagina return to its natural pH more rapidly, potentially mitigating the discomfort and microbial imbalance that can follow intercourse.

Navigating a Novel Regulatory Path

The designation of Livi as a "first-of-its-kind" device is more than a marketing claim; it reflects a significant regulatory achievement. The product's novelty means there was no existing, legally marketed device (a "predicate") to which it could be compared. This suggests Livi likely underwent the FDA's De Novo classification process, a rigorous pathway for novel, low-to-moderate risk devices. Successfully navigating this process establishes a new regulatory category, validating the device's unique function and setting a benchmark for future innovations in this space.

Livi enters a market populated by indirect competitors and traditional practices. Products like feminine wipes and washes offer external cleansing, while douches, which are widely discouraged by gynecologists for disrupting the vaginal microbiome, offer an internal (but often harmful) approach. Livi distinguishes itself by being an internal, absorptive, and non-disruptive solution specifically cleared for its post-intercourse purpose.

From Taboo Topic to Empowered Choice

Beyond its clinical application, the launch of Livi represents a cultural step forward. It brings a private, often-ignored aspect of female sexual health into the open, backed by medical technology and regulatory approval. By creating a legitimate solution, LiviWell is helping to destigmatize the conversation around post-sex realities, empowering women to seek comfort without shame or embarrassment. This shift encourages a more open dialogue about intimate wellness between partners, friends, and healthcare providers.

Investor confidence appears strong. In October 2025, LiviWell closed a $3.3 million oversubscribed seed funding round led by Atlantic Venture Studio, a subsidiary of Atlantic Health System, bringing its total funding to approximately $3.8 million. This capital is fueling the company's ambitious go-to-market strategy.

Livi is expected to launch for direct-to-consumer online sales in the United States by the end of May 2026. LiviWell has announced plans for future expansion into brick-and-mortar retail channels and international markets, signaling its intent to make this new category of care widely accessible. With its launch, LiviWell is not just selling a product; it is proposing a new, more comfortable standard for women's intimate health.